Cannabinoid receptor activation reduces TNFα-Induced surface localization of AMPAR-type glutamate receptors and excitotoxicity

Neuropharmacology

Volumn 58, Issue 2, 2010, Pages 551-558

  Zhao, Pingwei ^a,b   Leonoudakis, Dmitri ^a   Abood, Mary E ^a,b   Beattie, Eric C ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

AMPA receptor; Cannabinoid receptor; Excitotoxicity; Glutamate receptor; Neuroprotection

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; AMPA RECEPTOR; ANANDAMIDE; CANNABINOID 1 RECEPTOR; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; EXCITOTOXICITY; EXOCYTOSIS; HIPPOCAMPUS; IN VITRO STUDY; NERVE CELL CULTURE; NERVE CELL MEMBRANE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT;

ANIMALS; BENZOXAZINES; CELL DEATH; CELL MEMBRANE; CELLS, CULTURED; EXOCYTOSIS; HIPPOCAMPUS; KAINIC ACID; MORPHOLINES; NAPHTHALENES; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, AMPA; RECEPTORS, CANNABINOID; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VIDEO RECORDING;

EID: 72149122908     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.07.035     Document Type: Article

References (64)

1. Abood M.E., Rizvi G., Sallapudi N., and McAllister S.D. Activation of the CB(1) cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity. Neurosci. Lett. 309 (2001) 197-201
2. Aras M.A., Hartnett K.A., and Aizenman E. Assessment of cell viability in primary neuronal cultures. Curr. Protoc. Neurosci. (2008) (Chapter 7), Unit 7 18
3. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., Beattie M.S., and Malenka R.C. Control of synaptic strength by glial TNFalpha. Science 295 (2002) 2282-2285
4. Bernardino L., Xapelli S., Silva A.P., Jakobsen B., Poulsen F.R., Oliveira C.R., Vezzani A., Malva J.O., and Zimmer J. Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J. Neurosci. 25 (2005) 6734-6744
5. Burnashev N., Khodorova A., Jonas P., Helm P.J., Wisden W., Monyer H., Seeburg P.H., and Sakmann B. Calcium-permeable AMPA-kainate receptors in fusiform cerebellar glial cells. Science 256 (1992) 1566-1570
6. Carriedo S., Yin H., and Weiss J. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 16 (1996) 4069-4079
7. Chao C.C., and Hu S. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16 (1994) 172-179
8. Chevaleyre V., Takahashi K.A., and Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 29 (2006) 37-76
9. Davidkova G., and Carroll R.C. Characterization of the role of microtubule-associated protein 1B in metabotropic glutamate receptor-mediated endocytosis of AMPA receptors in hippocampus. J. Neurosci. 27 (2007) 13273-13278
10. Di Marzo V., Bifulco M., and De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discov. 3 (2004) 771-784
11. Feldmeyer D., Kask K., Brusa R., Kornau H., Kolhekar R., Rozov A., Burnashev N., Jensen V., Hvalby O., Sprengel R., and Seeburg P. Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B. Nat. Neurosci. 2 (1999) 57-64
12. Ferguson A.R., Christensen R.N., Gensel J.C., Miller B.A., Sun F., Beattie E.C., Bresnahan J.C., and Beattie M.S. Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J. Neurosci. 28 (2008) 11391-11400
13. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., and Eisel U. Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 22 (2002) RC216
14. Gao C., Sun X., and Wolf M.E. Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons. J. Neurochem. 98 (2006) 1664-1677
15. Gelbard H.A., Dzenko K.A., DiLoreto D., del Cerro C., del Cerro M., and Epstein L.G. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev. Neurosci. 15 (1993) 417-422
16. Gensel J.C., Tovar C.A., Hamers F.P., Deibert R.J., Beattie M.S., and Bresnahan J.C. Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats. J. Neurotrauma 23 (2006) 36-54
17. Glass T.F., Reeves B., and Sharp F.R. The impact of excitotoxic blockade on the evolution of injury following combined mechanical and hypoxic insults in primary rat neuronal culture. Neurobiol. Dis. 17 (2004) 378-384
18. Grooms S.Y., Opitz T., Bennett M.V., and Zukin R.S. Status epilepticus decreases glutamate receptor 2 mRNA and protein expression in hippocampal pyramidal cells before neuronal death. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3631-3636
19. Grossman S.D., Wolfe B.B., Yasuda R.P., and Wrathall J.R. Alterations in AMPA receptor subunit expression after experimental spinal cord contusion injury. J. Neurosci. 19 (1999) 5711-5720
20. Hermann G.E., Rogers R.C., Bresnahan J.C., and Beattie M.S. Tumor necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord. Neurobiol. Dis. 8 (2001) 590-599
21. Hill E.L., Gallopin T., Ferezou I., Cauli B., Rossier J., Schweitzer P., and Lambolez B. Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J. Neurophysiol. (2007)
22. Hollmann M., Hartley M., and Heinemann S. Ca2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252 (1991) 851-853
23. Howlett A.C. The cannabinoid receptors. Prostaglandins Other Lipid Mediat. 68-69 (2002) 619-631
24. Hurst D., Umejiego U., Lynch D., Seltzman H., Hyatt S., Roche M., McAllister S., Fleischer D., Kapur A., Abood M., Shi S., Jones J., Lewis D., and Reggio P. Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction. J. Med. Chem. 49 (2006) 5969-5987
25. Kim S.H., Won S.J., Mao X.O., Jin K., and Greenberg D.A. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity. Mol. Pharmacol. 69 (2006) 691-696
26. Kwak S., and Weiss J.H. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr. Opin. Neurobiol. 16 (2006) 281-287
27. Leonoudakis D., Braithwaite S.P., Beattie M.S., and Beattie E.C. TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity?. Neuron Glia Biol. 1 (2004) 263-273
28. Leonoudakis D., Zhao P., and Beattie E.C. Rapid tumor necrosis factor alpha-induced exocytosis of glutamate receptor 2-lacking AMPA receptors to extrasynaptic plasma membrane potentiates excitotoxicity. J. Neurosci. 28 (2008) 2119-2130
29. Leterrier C., Laine J., Darmon M., Boudin H., Rossier J., and Lenkei Z. Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors. J. Neurosci. 26 (2006) 3141-3153
30. Lock C., Oksenberg J., and Steinman L. The role of TNFalpha and lymphotoxin in demyelinating disease. Ann. Rheum. Dis. 58 Suppl. 1 (1999) I121-I128
31. Mackie K. From active ingredients to the discovery of the targets: the cannabinoid receptors. Chem. Biodivers 4 (2007) 1693-1706
32. Malinow R., and Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 25 (2002) 103-126
33. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutierrez S.O., van der Stelt M., Lopez-Rodriguez M.L., Casanova E., Schutz G., Zieglgansberger W., Di Marzo V., Behl C., and Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
34. McDonald N.A., Henstridge C.M., Connolly C.N., and Irving A.J. An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor. Mol. Pharmacol. 71 (2007) 976-984
35. Mihai G., Nout Y.S., Tovar C.A., Miller B.A., Schmalbrock P., Bresnahan J.C., and Beattie M.S. Longitudinal comparison of two severities of unilateral cervical spinal cord injury using magnetic resonance imaging in rats. J. Neurotrauma 25 (2008) 1-18
36. Nagatsu T., Mogi M., Ichinose H., and Togari A. Cytokines in Parkinson's disease. J. Neural Transm. Suppl. (2000) 143-151
37. Nemeth Z.H., Hasko G., Szabo C., and Vizi E.S. Amrinone and theophylline differentially regulate cytokine and nitric oxide production in endotoxemic mice. Shock 7 (1997) 371-375
38. New D.R., Maggirwar S.B., Epstein L.G., Dewhurst S., and Gelbard H.A. HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism. J. Biol. Chem. 273 (1998) 17852-17858
39. Ogoshi F., Yin H.Z., Kuppumbatti Y., Song B., Amindari S., and Weiss J.H. Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons. Exp. Neurol. 193 (2005) 384-393
40. Oguro K., Oguro N., Kojima T., Grooms S.Y., Calderone A., Zheng X., Bennett M.V., and Zukin R.S. Knockdown of AMPA receptor GluR2 expression causes delayed neurodegeneration and increases damage by sublethal ischemia in hippocampal CA1 and CA3 neurons. J. Neurosci. 19 (1999) 9218-9227
41. Oh M.C., Derkach V.A., Guire E.S., and Soderling T.R. Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation. J. Biol. Chem. 281 (2006) 752-758
42. Patel M.N., Yim G.K., and Isom G.E. N-methyl-D-aspartate receptors mediate cyanide-induced cytotoxicity in hippocampal cultures. Neurotoxicology 14 (1993) 35-40
43. Perry R.T., Collins J.S., Wiener H., Acton R., and Go R.C. The role of TNF and its receptors in Alzheimer's disease. Neurobiol. Aging 22 (2001) 873-883
44. Pickering M., Cumiskey D., and O'Connor J.J. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp. Physiol. 90 (2005) 663-670
45. Reimann-Philipp U., Ovase R., Weigel P.H., and Grammas P. Mechanisms of cell death in primary cortical neurons and PC12 cells. J. Neurosci. Res. 64 (2001) 654-660
46. Salio C., Cottone E., Conrath M., and Franzoni M.F. CB1 cannabinoid receptors in amphibian spinal cord: relationships with some nociception markers. J. Chem. Neuroanat. 24 (2002) 153-162
47. Sanchez C., Rueda D., Segui B., Galve-Roperh I., Levade T., and Guzman M. The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan. Mol. Pharmacol. 59 (2001) 955-959
48. Shen M., and Thayer S. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol. Pharmacol. 54 (1998) 459-462
49. Shen M., and Thayer S. Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. Mol. Pharmacol. 55 (1999) 8-13
50. Shohami E., Ginis I., and Hallenbeck J.M. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 10 (1999) 119-130
51. Snyder E.M., Philpot B.D., Huber K.M., Dong X., Fallon J.R., and Bear M.F. Internalization of ionotropic glutamate receptors in response to mGluR activation. Nat. Neurosci. 4 (2001) 1079-1085
52. Stellwagen D., Beattie E.C., Seo J.Y., and Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci. 25 (2005) 3219-3228
53. Stellwagen D., and Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 440 (2006) 1054-1059
54. Sun X., Zhao Y., and Wolf M.E. Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. J. Neurosci. 25 (2005) 7342-7351
55. Szelenyi J. Cytokines and the central nervous system. Brain Res. Bull. 54 (2001) 329-338
56. Wade M.R., Tzavara E.T., and Nomikos G.G. Cannabinoids reduce cAMP levels in the striatum of freely moving rats: an in vivo microdialysis study. Brain Res. 1005 (2004) 117-123
57. Xiao M.Y., Zhou Q., and Nicoll R.A. Metabotropic glutamate receptor activation causes a rapid redistribution of AMPA receptors. Neuropharmacology 41 (2001) 664-671
58. Yang L., Lindholm K., Konishi Y., Li R., and Shen Y. Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J. Neurosci. 22 (2002) 3025-3032
59. Ying Z., Babb T.L., Comair Y.G., Bushey M., and Touhalisky K. Increased densities of AMPA GluR1 subunit proteins and presynaptic mossy fiber sprouting in the fascia dentata of human hippocampal epilepsy. Brain Res. 798 (1998) 239-246
60. Yudowski G.A., Puthenveedu M.A., Leonoudakis D., Panicker S., Thorn K.S., Beattie E.C., and von Zastrow M. Real-time imaging of discrete exocytic events mediating surface delivery of AMPA receptors. J. Neurosci. 27 (2007) 11112-11121
61. Zhang H.H., Halbleib M., Ahmad F., Manganiello V.C., and Greenberg A.S. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51 (2002) 2929-2935
62. Zhang J.M., Li H., Liu B., and Brull S.J. Acute topical application of tumor necrosis factor alpha evokes protein kinase A-dependent responses in rat sensory neurons. J. Neurophysiol. 88 (2002) 1387-1392
63. Zhao X., Bausano B., Pike B.R., Newcomb-Fernandez J.K., Wang K.K., Shohami E., Ringger N.C., DeFord S.M., Anderson D.K., and Hayes R.L. TNF-alpha stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures. J. Neurosci. Res. 64 (2001) 121-131
64. Zou J.Y., and Crews F.T. TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res. 1034 (2005) 11-24